When the FDA published the Matta et al. studies in 2019 and 2020, the agency issued accompanying statements clarifying the meaning of the results. The FDA explicitly stated that exceeding the 0.5 ng/mL threshold does not indicate that these ingredients are unsafe. The threshold is an administrative trigger that means additional nonclinical toxicology studies are required before the ingredient can receive GRASE (Generally Recognized as Safe and Effective) status without further data. The FDA emphasized that people should continue using sunscreen and that the studies should not be interpreted as evidence of harm. The agency maintained its recommendation for daily broad-spectrum sunscreen use.

Green et al. published results from the Nambour Skin Cancer Prevention Trial in the Journal of Clinical Oncology in 2011. This is the only large randomized controlled trial of sunscreen and melanoma. Residents of Nambour, Queensland, Australia were randomly assigned to daily sunscreen application or discretionary use and followed for over 10 years. The daily sunscreen group developed 11 new primary melanomas compared to 22 in the discretionary group - a 50% reduction. Invasive melanomas were also reduced. Melanoma kills approximately 20 Americans per day, making this prevention benefit substantial and directly relevant to any risk-benefit calculation about sunscreen chemical absorption.

Green et al. first reported results for non-melanoma skin cancer in The Lancet in 1999, with extended follow-up in Cancer Epidemiology, Biomarkers & Prevention in 2006. Among 1,621 randomized participants, daily sunscreen users had a 40 to 60% reduction in squamous cell carcinoma tumor rates over the entire follow-up period. This was a rigorous randomized trial with long follow-up, representing the highest level of evidence. Squamous cell carcinoma is the second most common cancer in humans. The demonstrated prevention of actual cancer in real people provides concrete evidence that the known benefits of sunscreen use are substantial, while evidence of harm from absorption remains theoretical.

Olsen et al. conducted a systematic review of human studies examining whether systemic levels of benzophenone-3 (oxybenzone) or octyl methoxycinnamate cause actual health effects. Published in PMC in 2020, the review concluded that elevated systemic BP-3 showed no adverse effect on male fertility, female fertility, female reproductive hormones, adiposity (body fat), fetal growth, child neurodevelopment, or sexual maturation in human populations. The authors stated that current evidence is not sufficient to support a causal relationship between elevated systemic levels and adverse health outcomes. Findings across studies were contradictory and lacked consistent replication.

The American Academy of Dermatology (AAD) issued a position statement responding to concerns about sunscreen chemical absorption. The AAD stated that there is no evidence of associated negative health effects from systemic absorption of sunscreen ingredients. They emphasized the principle that detection of a chemical in the bloodstream does not by itself constitute evidence of harm - absorption does not equal harm. The AAD noted that skin cancer affects 1 in 5 Americans over their lifetime, and approximately 20 Americans die from melanoma every day. They recommend broad-spectrum SPF 30 or higher for all individuals, maintaining that the proven cancer prevention benefits clearly outweigh any theoretical absorption concerns.

The FDA classifies only two sunscreen active ingredients as Generally Recognized as Safe and Effective (GRASE): zinc oxide and titanium dioxide. Multiple studies have demonstrated that these mineral filters do not penetrate beyond the outermost layer of the skin (stratum corneum), even when applied to damaged or compromised skin. Zero systemic absorption has been detected. These ingredients provide effective broad-spectrum UV protection through physical blocking and scattering of UV radiation. Their availability means that consumers concerned about chemical absorption have proven-safe alternatives that deliver equivalent sun protection without any bloodstream entry, making the claim that "sunscreen" is harmful overly broad.

The European Commission Scientific Committee on Consumer Safety (SCCS) issued an opinion on March 31, 2021 concluding that octocrylene is safe for consumer use at concentrations up to 10% in cream and lotion sunscreens and up to 9% in propellant sprays. This conclusion was reached after a comprehensive safety evaluation that specifically considered systemic absorption data. The SCCS is among the most conservative regulatory bodies for cosmetic ingredient safety worldwide, and their approval indicates that rigorous independent toxicologists found the evidence insufficient to conclude harm at real-world exposure levels. This stands in contrast to claims that all absorbed sunscreen chemicals are dangerous.

Sanchez et al. conducted a systematic review and meta-analysis of epidemiological studies examining the relationship between sunscreen use and melanoma risk. Published in the International Journal of Dermatology, the pooled analysis found no association between sunscreen use and increased melanoma incidence. The only randomized controlled trial (the Nambour trial) showed a protective effect. Regular sunscreen use consistently reduced skin cancer incidence across studies. If absorbed sunscreen chemicals were causing cancer at harmful levels, decades of epidemiological research involving millions of sunscreen users would be expected to show an increased cancer signal - but no such signal exists.

Krause et al. at the Technical University of Denmark published a comprehensive review in Environment International in 2023, combining a meta-analysis of human biomonitoring studies with a full toxicological assessment of benzophenone-3. They concluded that human epidemiological data on actual health effects remain limited and often inconclusive. Critically, they noted that dose levels used in animal toxicology studies that showed endocrine effects often far exceed realistic human exposure from sunscreen use. The disconnect between animal study doses and actual human exposure means that animal findings cannot be directly extrapolated to claim harm in people using sunscreen as directed.

The American Academy of Dermatology published data showing that misinformation about sunscreen chemical safety has measurable public health consequences. Their survey found that fears about sunscreen absorption have led more than 16 million Americans to reduce or stop sunscreen use entirely. These individuals face increased risk of UV-induced skin cancer - a known, proven, and well-quantified harm. The irony is that avoiding sunscreen due to unproven absorption fears exposes people to the proven carcinogen of ultraviolet radiation. UV radiation causes an estimated 9,500 skin cancer diagnoses per day in the US, making it a far more concrete and immediate danger than any theoretical harm from absorbed sunscreen chemicals.

A study published in Nature Scientific Reports in 2026 used advanced molecular analysis to demonstrate that sunscreen application substantially mitigates the molecular perturbations induced by repetitive UV exposure at the DNA level. The research showed that sunscreen maintains healthy skin at the molecular and cellular level, preventing the accumulation of mutations that lead to cancer development. This provides mechanistic evidence explaining how sunscreen prevents skin cancer - by physically blocking UV photons from reaching and damaging DNA in skin cells. The proven molecular protection mechanism demonstrates a direct, measurable health benefit that any absorption concern must be weighed against.